Tags : Nucleus Network

Novavax Signs a Clinical Trial Agreement with Nucleus Network to

Shots: Novavax deploys expertise of the Nucleus to commence P-I clinical study assessing NVX-CoV2373 for the first confirmed COVID-19 vaccines study outside the US. The P-I study is expected to be initiated in mid-May with its preliminary immunogenicity and safety results in July The study will be the third confirmed global COVID-19 vaccine trial and […]Read More